Effectiveness of anti-clotting meds after stent placement varied in people with diabetes
November 10, 2025
November 10, 2025
DALLAS, Texas, Nov. 10 [Category: Health Care] -- The American Heart Association posted the following news release:
* * *
Effectiveness of anti-clotting meds after stent placement varied in people with diabetes
*
Research Highlights:
* Two P2Y12 inhibitors often used interchangeably, ticagrelor and prasugrel (antiplatelet medications prescribed to prevent the formation of blood clots), had different impacts on outcomes in patient . . .
* * *
Effectiveness of anti-clotting meds after stent placement varied in people with diabetes
*
Research Highlights:
* Two P2Y12 inhibitors often used interchangeably, ticagrelor and prasugrel (antiplatelet medications prescribed to prevent the formation of blood clots), had different impacts on outcomes in patient . . .
